In prostate cancer cells, ELOVL5 expression was induced by androgen, and increased expression of ELOVL5 in prostate cancer was demonstrated in cultured cells, xenografts, and clinical tumors of prostate cancer (Centenera et al. 2021). The gene discussed is ELOVL5; the disease is prostate carcinoma.